Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0041228
Disease: African Trypanosomiasis
African Trypanosomiasis
0.050 GeneticVariation disease BEFREE In the present study, a LAMP test was designed from the serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense, the cause of the acute form of African sleeping sickness, and used to detect parasite DNA from processed and heat-treated infected blood samples. 18253475 2008
CUI: C0041228
Disease: African Trypanosomiasis
African Trypanosomiasis
0.050 GeneticVariation disease BEFREE The human serum resistance-associated (SRA) gene was identified in 28 (80%) of the 35 T.b. rhodesiense trypanosomes from parasitologically confirmed sleeping sickness cases, using the primers designed by Radwanska and in 27 (77.1%) of the same 35 T.b. rhodesiense trypanosomes using the primers designed by Gibson.However, about 20% of the 35 T.b. rhodesiense trypanosomes could not be detected by SRA-polymerase chain reaction (PCR) even when an aliquot of the first PCR was used in the second PCR, indicating that the gene may be absent in those trypanosomes or the trypanosomes could be having another variant of SRA not detectable by these primers since three variants of SRA genes have so far been identified or the amount of trypanosomal DNA extracted from infected blood was too low to be detected. 17135530 2006
CUI: C0041228
Disease: African Trypanosomiasis
African Trypanosomiasis
0.050 GeneticVariation disease BEFREE Blood from 231 patients with sleeping sickness in central Uganda and from 91 patients with sleeping sickness in northwest Uganda and south Sudan were screened for T b rhodesiense (detection of SRA gene) and T b gambiense (detection of TgsGP gene). 16308383 2005
CUI: C0041228
Disease: African Trypanosomiasis
African Trypanosomiasis
0.050 GeneticVariation disease BEFREE Detection of Trypanosoma brucei rhodesiense in animals from sleeping sickness foci in East Africa using the serum resistance associated (SRA) gene. 15099811 2004
CUI: C0041228
Disease: African Trypanosomiasis
African Trypanosomiasis
0.050 GeneticVariation disease BEFREE Detection of the SRA gene could provide the basis for a simple diagnostic test to enable targeted control of T b rhodesiense in the domestic livestock reservoir, thereby reducing the public-health burden of sleeping sickness in east Africa. 11755607 2001
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 AlteredExpression group BEFREE The steroid receptor RNA activator 1 (SRA1) produces SRA long noncoding RNA (lncRNA) and SRA protein (SRAP), which regulate ER expression at the RNA and protein levels in some hormone-dependent tumors via an alternative splicing event. 27694140 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 AlteredExpression group BEFREE UHRF1 constitutes a complex with histone deacetylase 1 (HDAC1) and DNA methyltransferase 1 (DNMT1) via its SRA domain and represses the expression of several tumour suppressor genes (TSGs) including p16INK4A, hMLH1, BRCA1 and RB1. 21496237 2011
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.030 Biomarker group BEFREE Furthermore, SRA:AIB1 was higher (Wilcoxon; P = 0.0058) in tumors compared with normal tissues. 11103781 2000
CUI: C0272285
Disease: Heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia
0.020 Biomarker disease BEFREE Overall, the whole blood aggregation method provided a reasonable alternative to SRA for identifying functional HIT. 29678479 2018
CUI: C0272285
Disease: Heparin-induced thrombocytopenia
Heparin-induced thrombocytopenia
0.020 Biomarker disease BEFREE The implementation of a centralized hospital-wide protocol via a multidisciplinary task force that coordinates testing and treatment of patients suspected of having HIT led to a substantial reduction in PF4 and SRA testing, as well as use of DTIs, resulting in a safe and cost-effective approach for the diagnosis and treatment of HIT. 29185142 2018
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.020 Biomarker disease BEFREE The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. 22330138 2012
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 Biomarker disease BEFREE The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. 22330138 2012
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.020 AlteredExpression disease BEFREE Western blot showed that SRA protein was expressed at a higher level in PC-3 than in LNCaP cells, suggesting that SRA may be related to hormone-independent growth of prostate cancer. 16607388 2006
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 AlteredExpression disease BEFREE Western blot showed that SRA protein was expressed at a higher level in PC-3 than in LNCaP cells, suggesting that SRA may be related to hormone-independent growth of prostate cancer. 16607388 2006
CUI: C0004610
Disease: Bacteremia
Bacteremia
0.010 GeneticVariation disease BEFREE By sequencing a representative collection of 146 <i>E. faecalis</i> strains isolated from hospital outbreaks, food, animals, and colonization of healthy human individuals, we established a novel cgMLST scheme with 1,972 gene targets within the Ridom SeqSphere<sup>+</sup> software.To test the <i>E. faecalis</i> cgMLST scheme and assess the typing performance, different collections comprising environmental and bacteremia isolates, as well as all publicly available genome sequences from the NCBI and SRA databases, were analyzed. 30651394 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 Biomarker group BEFREE Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain. 31238111 2019
CUI: C0007113
Disease: Rectal Carcinoma
Rectal Carcinoma
0.010 Biomarker disease BEFREE To recruit all metastatic lymph nodes in rectal cancer surgery, it is important to include the sigmoid mesentery in the specimen, but not to perform a central ligation of the IMA compared with ligation of the SRA close to the left colic artery (LCA). 30744943 2019
CUI: C0007222
Disease: Cardiovascular Diseases
Cardiovascular Diseases
0.010 Biomarker group BEFREE Downregulation of lncRNA-SRA participates in the development of cardiovascular disease in type II diabetic patients. 30988713 2019
CUI: C0038525
Disease: Subarachnoid Hemorrhage
Subarachnoid Hemorrhage
0.010 Biomarker disease BEFREE This study revealed that inflow angle < 90 degrees and size ratio, but not absolute size, may highly predict poorer grade of SAH in SRA. 31397878 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 Biomarker group BEFREE Role of UHRF1 in malignancy and its function as a therapeutic target for molecular docking towards the SRA domain. 31238111 2019
CUI: C0004096
Disease: Asthma
Asthma
0.010 Biomarker disease BEFREE EBT (°C) was significantly higher in patients with SRA compared to those with mild to moderate asthma (median IQR 34.2 [32.4-34.6] versus 31.8 [26.3-34.1], p = 0.001). 29176061 2018
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.010 Biomarker disease BEFREE SRA is reliable in predicting incident AF with a high negative predictive value. 29205690 2018
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.010 Biomarker group BEFREE In a monocentric prospective study 105 out of 389 patients with cryptogenic stroke despite extensive diagnostic workup were investigated with two additional cardiac monitoring tools: (a) 20 months' monitoring by ICM and (b) SRA during hospitalization at the stroke unit. 29205690 2018
CUI: C0009777
Disease: Conn Adenoma
Conn Adenoma
0.010 AlteredExpression disease BEFREE A/C = cortisol-corrected aldosterone concentration; ACE = angiotensin-converting enzyme; APA = aldosterone-producing adenoma; APCC = aldosterone-producing cell cluster; ARB = angiotensin receptor blocker; ARR = aldosterone-to-renin ratio; AVS = adrenal venous sampling; CT = computed tomography; ENaC = epithelial sodium channel; GRA = glucocorticoid remediable aldosteronism; IHA = idiopathic hyperaldosteronism; LI = lateralization ratio; MR = mineralocorticoid receptor; MRI = magnetic resonance imaging; PA = primary aldosteronism; PRA = plasma renin activity; SRA = surgical remediable aldosteronism. 28332881 2017
CUI: C0015967
Disease: Fever
Fever
0.010 Biomarker phenotype BEFREE Er<sup>3+</sup>/Yb<sup>3+</sup> co-doped SrAl<sub>2</sub>O<sub>4</sub> (SRA: Er<sup>3+</sup>, Yb<sup>3+</sup>) phosphor has been synthesized by high temperature solid state reaction technique. 28570986 2017